|
|
Kevin McPartland By Beverly Chandler, Opalesque London:
Financial markets' research and strategic advisory firm focused on capital markets, TABB Group has commented on SunGard’s recent report on likely trends for OTC derivatives for 2012.
Founded in 2003 and based on first person knowledge of a subject, TABB Group analyzes and quantifies the investing value chain from the fiduciary, investment manager, broker, exchange and custodian, as well as the operations that support them.
Commenting on the SunGard predictions for OTC markets in 2012, Kevin McPartland, principal and director of fixed income research at TABB Group, said, "Though clearing is getting faster, it is also about to get much more complicated. Regulatory mandates and good old-fashioned competition will force more complex products into the clearing environment. Furthermore, portfolios that once contained only OTC derivatives products will now contain a mix of both cleared and non-cleared trades. This creates risk management issues as calculating margin becomes even more complicated. As a result, technology will become a significant part of each market participant’s competitive advantage."
SunGard’s head of strategy for capital markets business, Peter Banham, said, "Regulatory changes are transforming the OTC derivatives space, from execution to settlement. Market participants need to manage large volumes of data in order to clear and process trades....................... To view our full article Click here
|
|
RSS
